Viridian reports positive news from ongoing trial for patients with Thyroid Eye Disease
Patients with active thyroid eye disease (TED) could benefit from rapid and significant improvements after…
August 16, 2022 - 3 minutes
Best in Biotech
The five hottest private biotech companies in San Diego
Within San Diego lies one of the biggest biotech hubs in the U.S. We’ve listed…
August 16, 2022 - 6 minutes
News and Trends
Merck puts up to $37B into Orna Therapeutics circular RNA collaboration
Merck, also known as MSD outside the U.S. and Canada, and Orna Therapeutics, a biotech…
August 16, 2022 - 3 minutes
News and Trends
Remedium raises more funds for osteoarthritis gene therapy candidate
Remedium Bio, Inc., a biotech company developing novel gene therapies, has closed more than $2.3…
August 16, 2022 - 3 minutes
What's New
MoreProgrammable medicines company Senda Biosciences closes $123M series C financing
U.S.-headquartered Senda Biosciences, Inc. has completed $123 million in series C financing, bringing its total…
August 16, 2022 - 3 minutes
Patient dosed in phase 1 trial evaluating treatment for those with tumors and malignancies
The first patient has been dosed in a phase 1 trial evaluating a monotherapy treatment…
August 16, 2022 - 3 minutes
ADC Therapeutics announces series of financial moves including $175M loan from Owl Rock
ADC Therapeutics has announced a series of major strategic transactions involving hundreds of millions of…
August 16, 2022 - 3 minutes
Gannex’ first patient dosed in study for treatment of primary biliary cholangitis
A study looking at a treatment for primary biliary cholangitis (PBC) has this month (August)…
August 16, 2022 - 3 minutes
Pneumagen embarks on phase 2 proof of concept influenza study
Biotech company Pneumagen says the first person has been dosed in its phase 2 controlled…
August 16, 2022 - 2 minutes
Inhibrx chondrosarcoma treatment gets EC orphan medicinal product designation
Following a positive opinion from the European Medicines Agency (EMA), the European Commission (EC) has…
August 16, 2022 - 2 minutes
Genentech lymphoma treatment gets FDA approval
Genentech, a part of the Roche Group, says the U.S. Food and Drug Administration (FDA)…
August 16, 2022 - 4 minutes
Sponsored
by ProteoGenix
Optimizing bioproduction using transient expression systems
During drug development, biologics often fail to transition from the preclinical to the clinical stage,…
August 16, 2022 - 7 minutes
From Our Partners
View More
Sponsored
by ProteoGenix
Optimizing bioproduction using transient expression systems
Sponsored
by Merck
How efficient lab inventory management can become a driver for success
Sponsored
by Medpace
A toolkit for emerging biotechs: practical advice for navigating challenges and advancing clinical development
Sponsored
by WuXi Advanced Therapies
Streamlining CAR-T cell therapy manufacturing: a platform approach
Download our industry reports
View all our reports
